ORIGINAL RESEARCH
Published on 22 Oct 2025
Integrative bioinformatics and experimental validation unveil CRISP3 as a hypoxia-, epithelial mesenchymal transition-, and immune-related prognostic biomarker and therapeutic target in breast cancer
doi 10.3389/fimmu.2025.1634399
- 171 views